188 related articles for article (PubMed ID: 20565808)
1. Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.
Gleicher N; Weghofer A; Barad DH
Reprod Biol Endocrinol; 2010 Jun; 8():64. PubMed ID: 20565808
[TBL] [Abstract][Full Text] [Related]
2. How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields.
Gleicher N; Darmon SK; Kushnir VA; Weghofer A; Wang Q; Zhang L; Albertini DF; Barad DH
Endocrine; 2016 Nov; 54(2):476-483. PubMed ID: 27510172
[TBL] [Abstract][Full Text] [Related]
3. Utility of age-specific serum anti-Müllerian hormone concentrations.
Barad DH; Weghofer A; Gleicher N
Reprod Biomed Online; 2011 Mar; 22(3):284-91. PubMed ID: 21269880
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of combined FSH and AMH observations in infertile women.
Gleicher N; Kim A; Kushnir V; Weghofer A; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
J Clin Endocrinol Metab; 2013 May; 98(5):2136-45. PubMed ID: 23533225
[TBL] [Abstract][Full Text] [Related]
5. Toward a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo) hormone ratios per retrieved oocyte.
Gleicher N; Kim A; Weghofer A; Barad DH
J Clin Endocrinol Metab; 2012 Mar; 97(3):995-1004. PubMed ID: 22170712
[TBL] [Abstract][Full Text] [Related]
6. Discordance between day-3 follicle stimulating hormone & anti-Müllerian hormone is predictive of clinical pregnancy during fertility treatment.
Butler WJ; Pico A; Hawkins KC; Younis AI
Gynecol Endocrinol; 2021 Sep; 37(9):798-801. PubMed ID: 33355011
[TBL] [Abstract][Full Text] [Related]
7. Age and Serum AMH and FSH Levels as Predictors of the Number of Oocytes Retrieved from Chromosomal Translocation Carriers after Controlled Ovarian Hyperstimulation: Applicability and Limitations.
Shilenkova YV; Pendina AA; Mekina ID; Efimova OA; Komarova EM; Lesik EA; Ishchuk MA; Fedorova EM; Chiryaeva OG; Petrova LI; Dudkina VS; Talantova OE; Gzgzyan AM; Kogan IY
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375549
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Anti-Müllerian Hormone and
Sun XY; Lan YZ; Liu S; Long XP; Mao XG; Liu L
Front Endocrinol (Lausanne); 2020; 11():595448. PubMed ID: 33343511
[TBL] [Abstract][Full Text] [Related]
9. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
[TBL] [Abstract][Full Text] [Related]
10. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
[TBL] [Abstract][Full Text] [Related]
11. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
Burks HR; Ross L; Opper N; Paulson E; Stanczyk FZ; Chung K
Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
[TBL] [Abstract][Full Text] [Related]
12. Random anti-Müllerian hormone predicts ovarian response in women with high baseline follicle-stimulating hormone levels : anti-Müllerian hormone in poor responders in assisted reproductive treatment.
Celik H; Bıldırcın D; Güven D; Cetinkaya MB; Alper T; Batuoğlu AS
J Assist Reprod Genet; 2012 Aug; 29(8):797-802. PubMed ID: 22573035
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
[TBL] [Abstract][Full Text] [Related]
14. Antimullerian hormone in cases of different reproductive pathologies.
Barbakadze L; Kristasashvili J
Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
[TBL] [Abstract][Full Text] [Related]
15. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
[TBL] [Abstract][Full Text] [Related]
16. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
[TBL] [Abstract][Full Text] [Related]
17. The role of ovarian reserve markers in prediction of clinical pregnancy.
Zebitay AG; Cetin O; Verit FF; Keskin S; Sakar MN; Karahuseyinoglu S; Ilhan G; Sahmay S
J Obstet Gynaecol; 2017 May; 37(4):492-497. PubMed ID: 28421902
[TBL] [Abstract][Full Text] [Related]
18. Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?
Wang S; Zhang Y; Mensah V; Huber WJ; Huang YT; Alvero R
J Ovarian Res; 2018 Jul; 11(1):60. PubMed ID: 30012195
[TBL] [Abstract][Full Text] [Related]
19. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
20. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]